A distributed research network model for post‐marketing safety studies: the Meningococcal Vaccine Study

Abstract

This study demonstrates the feasibility of using a distributed data network approach to perform large scale post-marketing safety analyses and is scalable to include additional organizations and data sources. We believe these results can inform the development of a large national surveillance system.